Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$560,895
-$92,358 QoQ
Shares Held
23,293
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,677
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROMAN BUTLER FULLERTON & CO holds $17,219,272 across 8 Drug Manufacturers - General names. PFE ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,469 | $8,958,543 | |
| 2 | JNJ |
Johnson & Johnson
|
11,481 | $2,915,829 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
27,189 | $1,566,630 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,695 | $1,117,307 | |
| 5 | ABBV |
AbbVie Inc.
|
4,372 | $1,100,170 | |
| 6 | AMGN |
Amgen Inc
|
1,956 | $708,306 | |
| 7 | PFE |
Pfizer Inc
This page
|
23,293 | $560,895 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,308 | $291,592 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $560,895 | 23,293 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $653,253 | 23,264 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $578,576 | 23,236 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $657,766 | 25,815 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $674,647 | 27,832 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $712,738 | 28,127 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $1,056,185 | 39,811 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $997,359 | 34,463 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,409,576 | 50,378 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,428,098 | 51,463 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $2,266,751 | 78,734 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,822,724 | 54,951 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $2,160,745 | 58,908 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $2,943,434 | 72,143 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $2,877,535 | 56,158 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $2,310,484 | 52,799 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $2,652,328 | 50,588 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $2,652,332 | 51,233 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $3,038,240 | 51,452 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $2,247,831 | 52,263 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,052,218 | 52,406 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,895,263 | 52,312 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $1,875,322 | 50,946 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $1,935,849 | 52,748 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $1,711,290 | 52,333 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $1,828,000 | 56,005 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||